Eupraxia Pharmaceuticals Inc.
EPRXHealthcare|Biotechnology|CA
$6.89
+0.29 (+4.39%)
DCF Value
$1.44
Tangible Book / Share
$1.95
Cash / Share
$2.02
Ownership Breakdown
82.8%
Float
66.1M
Shares Outstanding
54.7M
Float Shares
Major Holders (9)
Combined: 54.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Joseph S. Freedman | Individual | 9.00% | 5,843,215 | Mar 16, 2026 | 13D/G |
| Manchester Explorer, L.P | Partnership | 8.60% | 4,597,217 | Feb 17, 2026 | 13D/G |
| Beutel, Goodman & Co Ltd. | Investment adviser | 8.00% | 4,058,899 | Nov 14, 2025 | 13D/G |
| Robert Disbrow | Individual | 7.00% | 3,568,150 | Nov 14, 2025 | 13D/G |
| James E. Besser | Individual | 4.50% | 2,772,341 | Aug 13, 2026 | 13D/G |
| Morgan C. Frank | Individual | 4.30% | 2,664,780 | Aug 13, 2026 | 13D/G |
| Manchester Management Company, LLC | Other | 4.30% | 2,634,048 | Aug 13, 2026 | 13D/G |
| Manchester Management PR, LLC | Other | 4.30% | 2,634,048 | Aug 13, 2026 | 13D/G |
| Manchester Explorer, L.P. | Partnership | 4.10% | 2,511,121 | Aug 13, 2026 | 13D/G |